跳至主要内容
临床试验/CTRI/2024/06/069280
CTRI/2024/06/069280尚未招募3 期

A randomized control trial to study remission of type 2 diabetes with intensive lifestyle modification versus a combination of oral semaglutide and dapagliflozin as an add-on to metformin monotherapy in comparison to standard medical management.A randomized control trial to study remission of type 2 diabetes with intensive lifestyle modification versus a combination of oral semaglutide and dapagliflozin as an add-on to metformin monotherapy in comparison to standard medical management. - DIAREM 3

RAMA WALIA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方